Cablevision’s support of The Lustgarten Foundation ensures that 100% of every donation goes directly to pancreatic cancer research.

 

2006

Cambridge Research Institute
David Tuveson, M.D., Ph.D.
Novel Anti-K-ras Strategies in Ductal Pancreatic Cancer

Georgetown University Medical Center
Anna Riegel, Ph.D.
The Role of the Nuclear Receptor Coactivator AIB1in the Early Preneoplastic Stages of Pancreatic Cancer

Johns Hopkins Medical Institutions
Marcia Canto, M.D.
Screening for Early Pancreatic Neoplasia: A Multi-Center Study

Johns Hopkins Medical Institutions
Elizabeth Jaffee, M.D.
 Functional Genomic Approach to Identify Genes that are Pancreatic Cancer Immune Targets

Johns Hopkins Medical Institutions
Steven D. Leach, M.D.
 High-Throughput, In-Vivo Screening for Novel Pancreatic Cancer Drugs Using the Zebrafish System

Johns Hopkins Medical Institutions
Joshua Mendell, M.D., Ph.D.
The Role of MicroRNAs in the Pathogenesis of Pancreatic Cancer

Technical University of Munich
Roland Schmid, M.D.
Jens T. Svieke, M.D.
The Role of Notch Signaling in Pancreatic Cancer Development

University of Michigan Medical Center
Diane Simeone, M.D.
Pancreatic Cancer Stem Cells

University of Texas M.D. Anderson Cancer Center
George Halder, Ph.D.
A Novel Genetic System to Identify Ideal Cancer Drug Targets in Pancreatic Cancer

University of Utah
Lewis Charles Murtaugh, Ph.D.
Interdependence of Notch and Kras Signaling in Pancreatic Tumorigenesis

Join Now

Lustgarten Facebook Lustgarten Twitter Lustgarten YouTube channel

The Lustgarten Foundation
1111 Stewart Avenue, Bethpage, New York 11714
Toll Free: 1-866-789-1000 P: 516-803-2304 F: 516-803-2303

©2009 Lustgarten Foundation - 501(c)3 - CharityNavigator: 4 Stars